Your browser doesn't support javascript.
loading
Analysis of loco-regional failures in head and neck cancer after radical radiation therapy.
De Felice, Francesca; Thomas, Christopher; Barrington, Sally; Pathmanathan, Angela; Lei, Mary; Urbano, Teresa Guerrero.
Afiliação
  • De Felice F; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK; Department of Radiotherapy, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Thomas C; Department of Medical Physics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Barrington S; PET Imaging Centre, St Thomas' Hospital, Division of Imaging Sciences and Biomedical Engineering, King's College London, King's Health Partners, London, UK.
  • Pathmanathan A; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Lei M; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Urbano TG; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: Teresa.GuerreroUrbano@gstt.nhs.uk.
Oral Oncol ; 51(11): 1051-1055, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26506048
ABSTRACT

OBJECTIVES:

To investigate the anatomical distribution of loco-regional treatment failures (LRF) in patients with head and neck squamous cell carcinoma (HNSCC) in relation to clinical target volume (CTV) delineation. MATERIALS AND

METHODS:

56 patients with LRF were retrospectively identified. Patients were previously treated with radical intensity modulated radiotherapy (IMRT) +/- chemotherapy. Target volumes include gross tumour volume (GTV), its volumetric expansion of 10mm (GTV-HD), CTV high dose (CTV-HD) delineated by anatomic expansion from GTV and CTV low dose (CTV-LD) defined to receive a prophylactic dose. LRF were evaluated by PET-CT or CT scan. We analysed the association between sites of LRF and target volumes and dosimetry, using image co-registration. Based on percentage of volume that received 95% of prescribed dose, LRF were classified as in-field, marginal or out-field.

RESULTS:

Median interval time from end of treatment to LRF was 186days. 65 (95.6%) LRF were classified as in-field. Considering primary target volumes, 40 (58.8%) LRF occurred inside GTV, 13 (19.1%) in GTV-HD and 7 (10.3%) in CTV-HD. The overall 1-year and 2-year post-failure survival (PFS) was 45.8% and 24.2%, respectively. Post radiation LRF managed with salvage surgery had a significantly higher median PFS when compared with palliative treatments (p=0.003).

CONCLUSIONS:

The majority of LRF occurred within GTV/GTV-HD, suggesting it is safe to reduce the CTV to a volumetric expansion. Given the low incidence of geographical misses, future studies should be directed towards dose escalation of high-risk volumes. Potential reduction of RT-related toxicity with volumetric expansion could facilitate salvage surgery.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Radioterapia de Intensidade Modulada / Neoplasias de Cabeça e Pescoço / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Radioterapia de Intensidade Modulada / Neoplasias de Cabeça e Pescoço / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article